The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia

European Journal of Clinical Investigation

Volumn 27, Issue 1, 1997, Pages 3-9

  Levi, M ^a,b   Van Der Poll, T ^a   Ten Cate, H ^a   Van Deventer, S J H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Blood coagulation; Cytokine; Disseminated intravascular coagulation; Endotoxin; Fibrinolysis; Lipopolysaccharide; Sepsis

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 10; CYTOKINE; INTERLEUKIN 6; PLASMIN; THROMBIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR;

CELL CULTURE; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM CELL; ENDOTOXEMIA; FIBRINOLYSIS; HUMAN; IN VITRO STUDY; MODEL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS;

EID: 0031057343     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.570614.x     Document Type: Review

References (56)

1. Morrison DC, Ulevitch RJ. The effects of bacterial endotoxins on host mediation systems. Am J Pathol 1978;93:527-617.
2. Robboy SJ, Colman RW, Minna JD. Pathology of disseminated intravascular coagulation (DIC): analysis of 26 cases. Hum Pathol 1972;3:327-9.
3. Regoeczi E, Brain MC. Organ distribution of fibrin in disseminated intravascular coagulation. Br J Haematol 1969;17:73-9.
4. Marder VJ, Martin SE, Francis CW, Colman RW. Consumptive thrombohemorrhagic disorders. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 2nd edn. Philadelphia: JB Lippincott, 1987;975-1015.
5. Okusawa S, Gelfland JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin-1 induces a shock like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988;81:1162-72.
6. Zawilska K, Zozulinska M, Turowieckka Z, Blahut M, Drobnik L, Vinazzer H. The effect of a long-acting recombinant hirudin (PPEG hirudin) on experimental diseminated intravascuular coagulation (DIC) in rabbits. Thromb Res 1993;69:315-20.
7. Taylor Jr FB, Esmon CT, Hishaw LB. Summary of staging mechanism and intervention studies in the baboon model of E. coli sepsis. J Trauma 1991;12:197-204.
8. Hinshaw LB, Brackett DJ, Archer LT, Beller BK, Wilson MF. Detection of the hyperdynamic state of sepsis in the baboon during lethal E. coli infusion. J Trauma 1983;23:361-5.
9. Ten Cate H, Bauer KA, Levi M et al. The activation of factor IX and factor X by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest 1993;92:1207-12.
10. Levi M, Ten Cate H, Bauer KA et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifyllin or by a monoclonal anti-tissue factor antibody in a chimpanzee model. J Clin Invest 1994;93:114-20.
11. Hack CE, Thijs LG. The orchestra of mediators in the pathogenesis of septic shock. In: Vincent JL, ed. Update in Intensive Care and Emergency Medicine. Berlin: Springer, 1991:231-46.
12. Fong Y, Moldawer LL, Shires GT, Lowry SF. The biologic characteristics of cytokines and their clinical implication in surgical injury. Surg Gynecol Obstet 1990;170:363-78.
13. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex patterns of cytokines in serum from patients with meningococcal septic shock. Association between interleukin-6, interleukin-1 and fatal outcome. J Exp Med 1989;169: 333-8.
14. van Deventer SJH, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990;76:2520-6.
15. Nuijens JH, Huijbregts CCM, Eerenberg- Belmer AJM et al. Quantification of plasma factor XIIa-Cl-inhibitor and kallikrein-Cl-inhibitor complexes in sepsis. Blood 1988;72:184-8.
16. Pixley RA, De La Cadena R, Page J et al. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia: in vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest 1993;92:61-8.
17. Taylor, FB Jr, Chang A, Ruf W et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991;33:127-34.
18. Biemond BJ, Levi M, ten Cate H et al. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal antibody to factor VII/VIIa. Thromb Haemostas 1995;73:223-8.
19. Mason JW, Kleeberg U, Dolan P, Colman RW. Plasma kallikrein and Hageman factor in gram-negative bacteremia. Ann Intern Med 1970;73:545-51.
20. Kaufman N, Page JD, Pixley RA, Schein R, Schmaier AH, Colman RW. α2-Macroglobulin-kallikrein complexes detect contact system activation in heriditary angioedema and human sepsis. Blood. 1991;77:2660-7.
21. Taylor FB Jr, Emerson TE Jr, Chang AK, Blick KE. Antithrombin III prevents the lethal effects of E. coli infusion in baboons. Circ Shock 1988;26:227-35.
22. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J. Double-blind placebo-controlled trial of antithrombin III concentrate in septic shock with disseminated intravascular coagulation. Chest 1993;104:882-8.
23. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163:740-5.
24. Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 1988;8:5588-92.
25. Taylor FB, Chang Jr. A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987;79:918-25.
26. Taylor Jr FB. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: regulatory roles of proteins C. S, C4bBP and of inhibitors of tissue factor. Prog Clin Biol Res 1994;388:175-94.
27. Taylor FB, Chang A, Ferrel G et al. C4b-binding protein exacerbates the host response to Escherichia coli. Blood 1991;78: 357-63.
28. Sandset PM, Roise O, Aasen AO, Abildgaard U. Extrinsic pathway inhibitor in post-operative/post-traumatic septicemia. Haemostasis 1992;19:189-95.
29. Sandset PM, Warn-Cramer BJ, Maki SL, Rapaport SI. Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravsacular coagulation and the generalized Shwartzman reaction. Blood 1991;78:1496-502.
30. Warr TA, Rao LV, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by the administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990;75: 1481-89.
31. Suffredini AF, Harpel PC, Parillo JE. Promotion and subsequent inhibition of plasminogen activator after administration of intravenous endotoxin to normal subjects. New Eng J Med 1989;320: 1165-72.
32. Biemond BJ, Levi M, ten Cate H et al. Endotoxin-induced activation and inhibition of the fibrinolytic system: effects of various interventions in the cytokine and coagulation cascades in experimental endotoxemia in chimpanzees. Clin Sci 1995;88:587-94.
33. Van Hinsberg VWM, Sprengers ED, Kooistra T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemostas 1987;57:148-53.
34. Gelehrter TD, Sznycer-Laszuk R. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J Clin Invest 1986:77:165-70.
35. Giles AR, Nesheim ME, Herring SW, Hoogendoorn H, Stump DC, Heldebrant CM. The fibrinolytic potential of the normal primate following the generation of thrombin in vivo. Thromb Haemostas 1990;63:476-81.
36. Michie HR, Manogue KR, Spriggs DR et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988;318:1481-6.
37. de Boer JP, Wolbink GJ, Thijs LG, Baars JW, Wagstaff J, Hack CE. Interplay of complement and cytokines in the pathogenesis of septic shock. Immunopharmacology 1992;24:135-48.
38. Hesse DG, Tracey KJ, Fong Y. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988; 166:147-53.
39. Jansen PM, Boermeester MA, Fischer E et al. Contribution of intereleukin-1 to activation of coagulation and fibrinolysis, to neutrophil degranulation and the release of sPLA2 in sepsis. Blood 1995;86:1027-34.
40. Vassali P. The pathophysiology of tumor necrosis factor. Annu Rev Immunol 1992;10:411-42.
41. Gregory, SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989;9;2752-5.
42. Bauer KA, Ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 1989; 74:165-72.
43. van der Poll T, Buller HR, ten Cate H et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990;322:1622-7.
44. van der Poll T, Levi M, van Deventer SJH et al. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 1994;83:446-51.
45. van der Poll T, Levi M, Ten Cate H et al. Effect of postponed treatment with an ami-tumor necrosis factor F (AB')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees. Clin Exp Immunol 1995;100:21-5.
46. Hinshaw LB, Tekamp-Olson P, Chang ACK. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF). Circ Shock 1990;30:279-92.
47. Ollivier V, Houssaye S, Ternisien C. Endotoxin-induced tissue factor mRNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. Blood 1993;81:973-9.
48. van der Poll T, Levi M, Hack CE et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994;179:1253-9.
49. Stouthard J, Levi M, Hack CE et al. Interleukin 6 stimulates coagulation but not fibrinolysis in humans. Thromb Haemostas 1996;76:738-42.
50. Creasey AA, Chang ACK, Feigen L, Wun TC, Taylor FB Jr, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Eschericia coli septic shock. J Clin Invest 1993;91:2850-5.
51. van der Poll T, Levi M, Buller HR et al. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991;174: 729-33.
52. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone Jr MA, Loskutoff DJ. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 1988;263:5797-803.
53. Van den Berg EA, Sprengers ED, Jaye M, Burgess W, Maciag T, van Hinsbergh VWM. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells. Thromb Haemostas 1988; 60:63-8.
54. Bevilacqua MP, Prober JS, Majeau GR, Cotran RS, Gimbrone MA Jr. Interleukin 1 (IL-1) induces biosynthesis and cell expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618-23.
55. Fischer E, Marano MA, van Zee KJ et al. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock but fails to alter host-responses to sublethal endotoxemia. J Clin Invest 1992;89:1551-6.
56. Boermeester MA, van Leeuwen PAM, Coyle SM et al. Interleukin-1 receptor blockade in patients with sepsis syndrome: evidence that interleukin-1 contributes to the release of interleukin-6, elastase and phospholipase A2, and to the activation of the complement, coagulation and fibrinolytic systems. Arch Surg 1995;130:739-48.